7 results
Experience
Rare PTAB rehearing request granted for Finnegan client Incyte Rare PTAB rehearing request granted for Finnegan client Incyte
IPR2017-01256, PTAB, Judges Fitzpatrick, Hulse, Yang, Smith, Franklin
19-2011, Fed. Cir., Judges Hughs, Linn, Stark
Experience
Finnegan helps Intellia Therapeutics acquire Rewrite Therapeutics, Inc. for $45 million Finnegan helps Intellia Therapeutics acquire Rewrite Therapeutics, Inc. for $45 million
Intellia Therapeutics, Inc.
Experience
Finnegan tees up valuable patents for Eisai, leading to major strategic collaboration agreement Finnegan tees up valuable patents for Eisai, leading to major strategic collaboration agreement
Eisai Co., Ltd.
Experience
Prosecuting patents for startup Hutchison Medipharma Prosecuting patents for startup Hutchison Medipharma
Hutchison Medipharma
Experience
Startup sold to major drug company based on strength of patents Startup sold to major drug company based on strength of patents
Agouron Pharmaceuticals, Inc.
12 results
Event
2024 ACC SFBA Life Sciences Conference 2024 ACC SFBA Life Sciences Conference
March 19-21, 2024
Brisbane
Prosecution First Blog
Life Sciences Patent Drafting Tool: MPF Claims Life Sciences Patent Drafting Tool: MPF Claims
September 15, 2023
IP Health Blog
FDA Guidance on Quality Considerations for Clinical Research Involving Cannabis and Cannabis-Derived Compounds FDA Guidance on Quality Considerations for Clinical Research Involving Cannabis and Cannabis-Derived Compounds
February 24, 2023
Event
General Information on English Contracts for Pharmaceutical Products General Information on English Contracts for Pharmaceutical Products
February 22, 2022
Webinar
Prosecution First Blog
Got Pharmaceutical Means-Plus-Function Claims? Got Pharmaceutical Means-Plus-Function Claims?
August 17, 2020
European IP Blog
Polymorphs at the EPO - Where Are We Now? Polymorphs at the EPO - Where Are We Now?
June 9, 2020
Event
Patents and the Expectation of Success Doctrine Patents and the Expectation of Success Doctrine
January 8, 2020
Webinar
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.